
Sam Paglinco, DO
88 posts

Sam Paglinco, DO
@SamPaglinco
IBD advocate, physician and patient • Peds GI 💩• sloth lover 🦥• trying to make the world a better place 🌎• tweets are my own and not medical advice




So sad to see my mentee, GI fellow, researcher, and friend @SamPaglinco graduate and move on to great things. I know we will keep in touch especially since we have a research meeting on July 2nd. Picture from a card she gave me. A picture of us holding her research award.





NASPGHAN member @DrPasternak_IBD speaks before AZ Senate Finance & Commerce Cmte in favor of #SB1164 to restrict PBM non-medical switching. #NASPGHAN calls for swift passage of SB1164. #StateAdvocacy @AZSenateDems @AZSenateRepublicans @AZHouseGOP @AZHouseDems

📍 On January 19th, 2022, Cost Plus Drugs launched with 100 drugs... TODAY we are excited and proud to announce that we are adding OVER 1,000 NEW MEDICATIONS! 🚨 📢 This bring our total to 2,200+ medications on costplusdrugs.com! ✚ Go to costplusdrugs.com/medications/ to see if your medications are available!




@DCharabaty recommends in her editorial (bit.ly/49deqob) including rectal urgency w/ dz activity, decreased work productivity, & QOL in #UC & #CD in clinical care and as a clinical endpoint in #IBD therapeutic trials, based on a recent global study by @tinahamd


🦖 on the loose today @NCHforDocs @nationwidekids


The future is bright!!!❤️ Jr IBD Board!!! #ICNCC23f

So proud of my mentee @SamPaglinco presenting NCH data on the importance of checking infliximab levels early(@ week 6)






Updated Resources on ALL of the Adalimumab Biosimilars!!! u.osu.edu/biosimilars/av…

Ongoing call to action for our community to meaningfully and sustainably address inequities in pediatric #IBD for *all* our kids to have accessible, equitable, interdisciplinary, & excellent care @ImproveCareNow @ICNPatients #ICNCCF23





